Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study

INTRODUCTION: Dulaglutide is a long-acting glucagon-like peptide 1 receptor agonist that is administered once weekly for the treatment of type 2 diabetes. However, the immediate glucose-lowering effect of dulaglutide after the first administration and the factors affecting the efficacy of the drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Terui, Sakiko, Akamatsu, Ryoichi, Arai, Masanori, Inoue, Ryota, Okuyama, Tomoko, Kyohara, Mayu, Li, Jinghe, Tsuno, Takahiro, Miyashita, Daisuke, Togashi, Yu, Terauchi, Yasuo, Shirakawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519979/
https://www.ncbi.nlm.nih.gov/pubmed/34533697
http://dx.doi.org/10.1007/s13300-021-01147-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519979/
https://www.ncbi.nlm.nih.gov/pubmed/34533697
http://dx.doi.org/10.1007/s13300-021-01147-2

Ejemplares similares